Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre C Pereira

Showing results (301-310 of 348) with videos related to

Pageof 35
Sort By:
JAMA Cardiology|September 6, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical TrialChristoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, et al.
Circulation. Heart Failure|December 10, 2019
Baseline Characteristics of the VANISH CohortAnna Axelsson Raja, Ling Shi, Sharlene M Day, et al.
Frontiers in Immunology|October 17, 2022
Blood DNA methylation marks discriminate Chagas cardiomyopathy disease clinical formsPauline Brochet, Barbara Ianni, João P S Nunes, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
Nature Communications|July 10, 2023
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failureDanielle Rasooly, Gina M Peloso, Alexandre C Pereira, et al.
Hypertension (Dallas, Tex. : 1979)|February 22, 2018
Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment)Eduardo M Krieger, Luciano F Drager, Dante M A Giorgi, et al.
Current Biology : CB|November 19, 2019
The Genomic Impact of European Colonization of the AmericasLinda Ongaro, Marilia O Scliar, Rodrigo Flores, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Type 2 diabetes genetics in 125,000 admixed adults from Mexico CityJason M Torres, Jaime Berumen, Diego Aguilar-Ramirez, et al.
Circulation|May 19, 2020
A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic CardiomyopathyAnastasia Miron, Myriam Lafreniere-Roula, Chun-Po Steve Fan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2015
Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutationsFernanda S G Kehdy, Mateus H Gouveia, Moara Machado, et al.
Pageof 35

Showing results (301-310 of 348) with videos related to

Sort By:
Pageof 35
JAMA Cardiology|September 6, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical TrialChristoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, et al.
Circulation. Heart Failure|December 10, 2019
Baseline Characteristics of the VANISH CohortAnna Axelsson Raja, Ling Shi, Sharlene M Day, et al.
Frontiers in Immunology|October 17, 2022
Blood DNA methylation marks discriminate Chagas cardiomyopathy disease clinical formsPauline Brochet, Barbara Ianni, João P S Nunes, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
Nature Communications|July 10, 2023
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failureDanielle Rasooly, Gina M Peloso, Alexandre C Pereira, et al.
Hypertension (Dallas, Tex. : 1979)|February 22, 2018
Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment)Eduardo M Krieger, Luciano F Drager, Dante M A Giorgi, et al.
Current Biology : CB|November 19, 2019
The Genomic Impact of European Colonization of the AmericasLinda Ongaro, Marilia O Scliar, Rodrigo Flores, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Type 2 diabetes genetics in 125,000 admixed adults from Mexico CityJason M Torres, Jaime Berumen, Diego Aguilar-Ramirez, et al.
Circulation|May 19, 2020
A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic CardiomyopathyAnastasia Miron, Myriam Lafreniere-Roula, Chun-Po Steve Fan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2015
Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutationsFernanda S G Kehdy, Mateus H Gouveia, Moara Machado, et al.
Pageof 35